Job description
As Global Business Process Specialist for Demand to Pay, you will be a part of the Business Process Management Organization of D2P. You will support the continuous global harmonization, standardization and automation of the D2P processes, especially in the areas of Supplier Onboarding. The role establishes related standard Roche Services and Solutions (RSS) procurement and finance services for the Affiliates, in close cooperation with relevant deployment teams (e.g. ASPIRE). The role is familiar with the end-to-end process templates and uses them as a basis to define, describe and implement necessary configurations for each service recipient, in consultation with Global Business Process Managers.This role will be a direct contract with Roche until the end of 2026 (Renewable)As Global Business Process Specialist for Demand to Pay, you will be a part of the Business Process Management Organization of D2P. You will support the continuous global harmonization, standardization and automation of the D2P processes, especially in the areas of Supplier Onboarding. The role establishes related standard Roche Services and Solutions (RSS) procurement and finance services for the Affiliates, in close cooperation with relevant deployment teams (e.g. ASPIRE). The role is familiar with the end-to-end process templates and uses them as a basis to define, describe and implement necessary configurations for each service recipient, in consultation with Global Business Process Managers.
Responsibilities & skills
Strong presentation skills as well as written and verbal communication skills in English.Excellent understanding of Procure to Pay processes, specifically in the Supplier Onboarding areas.Strong influencing skills and ability to work in complex global networks with international teams and stakeholder communities.
Education
Possess a Bachelor or Master Degree in Business or Finance.
Experience
Ready to apply?
Sign in and make sure your profile and resume are up to date.
Roche
Roche was one of the first companies to bring targeted treatments to patients. With our combined strength in pharmaceuticals and diagnostics, we are better equipped than any other company to further drive personalised healthcare. Two-thirds of our Research and Development projects are being developed with companion diagnostics.We are the world's number 1 in biotech with 17 biopharmaceuticals on the market. Over half of the compounds in our product pipeline are biopharmaceuticals, enabling us to deliver better-targeted therapies.We have been at the forefront of cancer research and treatment for over 50 years, with medicines for breast, skin, colon, ovarian, lung and numerous other cancers.We offer doctors profound information to guide treatments and to answer more patients’ questions than any other company. And our tests enable hospitals and labs to deliver that information quickly and reliably.We invest around 9 billion Swiss francs in Research and Development every year because innovation is our lifeblood. This is amongst the highest Research and Development spends in the world across all industries.
View company profile